ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications

Geng, Xinqian; Li, Zheng; Yang, Ying*广东药学院; 云南大学; y
Frontiers in Endocrinology2022-5-27DOI: 10.3389/fendo.2022.907060
8被引6阅读
引用收藏
分享

摘要

Diabetes mellitus (DM) and its related complications are among the leading causes of disability and mortality worldwide. Substantial studies have explored epigenetic regulation that is involved in the modifications of DNA and proteins, but RNA modifications in diabetes are still poorly investigated. In recent years, posttranscriptional epigenetic modification of RNA (the so-called 'epitranscriptome') has emerged as an interesting field of research. Numerous modifications, mainly N-6 -methyladenosine (m(6)A), have been identified in nearly all types of RNAs and have been demonstrated to have an indispensable effect in a variety of human diseases, such as cancer, obesity, and diabetes. Therefore, it is particularly important to understand the molecular basis of RNA modifications, which might provide a new perspective for the pathogenesis of diabetes mellitus and the discovery of new therapeutic targets. In this review, we aim to summarize the recent progress in the epitranscriptomics involved in diabetes and diabetes-related complications. We hope to provide some insights for enriching the understanding of the epitranscriptomic regulatory mechanisms of this disease as well as the development of novel therapeutic targets for future clinical benefit.

学科与关键词

关键词
epitranscriptomicsdiabetesdiabetic cardiomyopathydiabetic nephropathydiabetic retinopathydiabetic woundsdiabetic neuropathy
相关
加载中…
  • H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications
    Zhu, Leiqi; Li, Yuanyang; Xia, Fangqi; Xue, Mengzhen; Wang, Yaqi; Jia, Dengke; Gao, Yan; Li, Luoying; Shi, Yue; Chen, Silong; Xu, Guangfu; Yuan, Chengfu*Current Pharmaceutical Design, 2022, 28(12): 1011-1018.被引 3
  • Molecular mechanisms of noncoding RNA and epigenetic regulation in obesity with consequent diabetes mellitus development
    Guo, Yi-Chen; Cao, Hao-Di; Lian, Xiao-Fen; Wu, Pei-Xian; Zhang, Fan; Zhang, Hua; Lu, Dong-Hui*World Journal of Diabetes, 2023, 14(11): 1621-1631.
  • The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.
    Ahmed, Sanabil Ali Hassan; Ansari, Suraiya Anjum; Mensah-Brown, Eric P K; Emerald, Bright Starling*Clin Epigenetics, 2020, 12(1): 104.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2022-05-27
卷期
第 13 卷
页码
907060
DOI
10.3389/fendo.2022.907060
期刊等级
3区
成果收录
SCIE
资助标注
Basic Research Program of Yunnan Province (Kunming Medical University Joint Special Project) [202101AY070001-276]; National Natural Science Foundation of China [82160159]; Key Field R&D Plan Project of Guangdong province [2019B020201002]; Innovative Team of Precise Prevention and Treatment against Metabolic Diseases of Yunnan University

作者

  • G

    Geng, Xinqian (第一作者)

    2 · yunnan univ

  • L

    Li, Zheng

    guangdong pharmaceut univ

查看全部 3 位作者收起作者
  • Y

    Yang, Ying (通讯)

    2 · yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417